In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3774-3782

  Malonne, H ^a   Farinelle, S ^a   Decaestecker, C ^a   Gordower, L ^a   Fontaine, J ^a   Chaminade, F ^a   Saucier, J M ^a   Atassi, G ^a   Kiss, R ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; N (2 DIMETHYLAMINOETHYL) 9 HYDROXY 5,6 DIMETHYL 6H PYRIDO[4,3 B]CARBAZOLE 1 CARBOXAMIDE; OLIVACINE; OLIVACINE DERIVATIVE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; COLON CANCER; DRUG DNA INTERACTION; DRUG MECHANISM; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; ELLIPTICINES; ETOPOSIDE; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0033818352     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
2. DNA topoisomerase targeting drugs: Mechanisms of action and perspectives
3. The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis
4. A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons
5. Clinical applications of anticancer drugs targeted to topoisomerase II
6. In vitro cytotoxicity of S16020-2, a new olivacine derivative
7. S16020-2, a new highly cytotoxic antitumor olivacine derivative: DNA interaction and DNA topoisomerase II inhibition
8. Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido{4,3-b}carbazole-1{N-(dialkylamino)alkyl}carboxami des, a new promising series of antitumor olivacine derivatives
9. Antitumor activity of S16020-2 in two orthotopic models of lung cancer
10. Experimental antitumor activity of S16020-2 in a panel of human tumors
11. Phase I clinical trial of the olivacine S16020
12. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5,6-dimethyl-6H-pyrido{4,3-b}carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity
13. Influence of gastrin on human astrocytic tumor cell proliferation
14. Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to Vinca-alkaloid, alkylating and intercalating drugs
15. Characterization of factors in routine laboratory protocols that significantly influence the Feulgen reaction
16. Characterization of alkylating versus intercalating anticancer drug-induced effects on cell survival, cell cycle kinetic and morphonuclear pattern of three neoplastic cell lines growing in vitro
17. Induction of apoptosis in human non-small lung carcinoma cells by the novel synthetic retinoid CD437
18. Setting up of an original computer-assisted methodology to characterize in vitro drug-induced anti-angiogenic effects
19. UICC Study Group on chemosensitivity testing of human tumors. Problems, applications, future prospects
20. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties
21. Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinoma
22. Die Alkaloide von Aspidosperma olivaceum m. ar. Aspidosperma Alkaloid 3, mitteilung
23. Preparation and antitumour activity of olivacine and some new analogs
24. A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs
25. Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: Structure-activity relationship
26. The biooxidation of cytotoxic ellipticine derivative: A key to structure-activity relationship studies?
27. Synthesis and antitumour activity of quaternary ellipticine glycosides, a series of novel and highly active antitumour agents
28. Structure-activity relationships in a series of newly synthesized 1-amino substituted ellipticine derivatives
29. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-{2-(dimethylamino)ethyl}acridine-4-carboxamide
30. The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, an antitumor agent
31. Comments on the treatment of breast cancer
32. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (Review)
33. Estrogen characterization in a transplantable mouse mammary tumor
34. Morphology of MXT mouse mammary tumors. Correlation with growth characteristics and hormone sensitivity
35. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors
36. Pathology of neoplasia and preneoplasia in rodents
37. Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents
38. The developmental cycle of B16 melanoma cell in culture